Education Important for Caregivers and Patients

Understanding the stage and type of cancer affects treatment and is important to understand:

"When someone says they have cancer, people often ask the stage of the cancer, as an indication of treatment or prognosis. However, with lymphomas, the specific type of disease (such as peripheral T-cell lymphoma) is equally as important as stage. Lymphoma is the most prevalent form of blood cancer in the United States, but there is a significant knowledge gap among Americans about this kind of cancer.

According to the National Cancer Institute, in 2010 an estimated 65,500 people are expected to be diagnosed with non-Hodgkin lymphoma and 8,500 people are expected to be diagnosed with Hodgkin lymphoma. A recent survey commissioned by the Lymphoma Research Foundation, and funded through a grant by Allos Therapeutics, revealed that despite those facts, a majority of American adults (86 percent) remain unaware that there are 67 different types of lymphoma - 61 types of non-Hodgkin lymphoma and six types of Hodgkin lymphoma. "

Read More: http://www.abc6onyourside.com/sections/lifestyle/tech/11571

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap